DS
SILK

David Shaw’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

David Shaw’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,154,781
Closed -$31.2M – 4990
2024
Q2 		$31.2M Sell
1,154,781
-444,710
-28% -$9.25M 0.03% 651
2024
Q1 		$29.3M Buy
1,599,491
+95,739
+6% +$1.52M 0.03% 702
2023
Q4 		$18.5M Buy
1,503,752
+1,362,939
+968% +$12.8M 0.02% 982
2023
Q3 		$2.11M Buy
140,813
+119,845
+572% +$2.49M ﹤0.01% 2520
2023
Q2 		$681K Sell
20,968
-84,714
-80% -$3.09M ﹤0.01% 3280
2023
Q1 		$4.14M Buy
105,682
+101,040
+2,177% +$4.94M ﹤0.01% 2099
2022
Q4 		$245K Buy
+4,642
New +$226K ﹤0.01% 4167

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

David Shaw's SILK Position: Q3 2024 in Review

David Shaw sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 1,154,781 shares — an estimated $31.2M sold.

David Shaw first reported a position in SILK in Q4 2022 and held it in 7 quarters. The position peaked at $31.2M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • David Shaw reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • David Shaw sold 1,154,781 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $31.2M.
  • David Shaw first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 7 quarters.
  • David Shaw's Silk Road Medical, Inc. Common Stock position peaked at $31.2M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.